CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
APAC
CANADA

About Us

Conference

Partner With Us

  • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    BioTech
    Cell and Gene Therapy
    Clinical Trial
    Drug Discovery and Development
    Life Science AI
    Regenerative Medicine
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    Bioprocessing
    Blood Bank
    CDMO
    Clinical Laboratory
    CRO
    Life Science Testing
    Skin Care
    Supplements
  • Business Services
    Life Science Consulting
    Life Science Facility Service
    Life Science Financial Services
    Life Science Marketing
    Life Science Recruitment Firms
    Pharma Wholesale and Distribution
    Pharmacy Management
    Regulatory and Compliance
    Regulatory Services
  • Leadership Perspectives
  • Innovation Insights
  • Research
  • News
  • Magazines
  • CXO Awards
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Grupo Dökka has been recognized by Life Sciences Review Magazine as the exclusive recipient of “Top Pharmaceutical Medicines Distribution Company in Latin America - 2025,” based on our proprietary methodology, reflecting its position in the industry. This profile has been developed by the Life Sciences Review research and editorial team based on insights from an interview with Eduardo Jiliberto, CEO.

Grupo Dökka
Integrated Path to Health and Well-Being

Grupo Dökka

Eduardo Jiliberto, Grupo Dökka | Life Science Review | Top Pharmaceutical Medicines Distribution Company in Latin AmericaEduardo Jiliberto, CEO
Driven by the purpose of bringing health and well-being to all, Grupo Dökka has emerged as one of Latin America’s leading forces in healthcare distribution. The company’s propulsion is a unique combination of pharmaceutical distribution, biomedical equipment distribution, retail pharmacies and digital health platforms.

“We have built an integrated ecosystem that addresses the needs of patients, healthcare institutions and governments alike,” says Mr. Eduardo Jiliberto, CEO. “Our vision blends innovation with inclusivity, creating a foundation for more equitable and efficient healthcare access across the region.”

Grupo Dökka’s pharmaceutical distribution proposition is built on logistics excellence, consulting, technology, and knowledge. Governments rely on the company as a trusted partner to ensure that low-income populations have timely access to medicine.

Grupo Dökka partners with prestigious international brands in biomedical equipment and collaborates closely with doctors and institutions. Its specialized teams ensure that innovative technologies are introduced through models designed for both sustainability and accessibility.

The retail side of the business reinforces its leadership position in Costa Rica. Two distinct pharmacy chains serve different needs: Farmacias La Bomba, which follows an “everyday low price” model, and Farmacia Fischel, which offers a high-end experience with wellness and dermocosmetic products.

Achieving Organizational Goals

Together, these chains meet the demands of diverse communities while strengthening the company’s reach in the consumer health market. Complementing this, Grupo Dökka has invested in a digital health ecosystem that seeks to promote prevention, provides reliable information, and helps patients reduce costs.
Grupo Dökka’s leadership philosophy is equally distinctive. Its management model, Direction, Alignment, and Commitment (DAC), ensures that every individual plays a leading role in achieving organizational goals. In place for four years, it has empowered more than 150 leaders across the company and reflects the belief that service excellence is non-negotiable.

Profitability and shareholder returns are achieved without compromising service quality, a balance made possible by engaging every employee in ownership of results.

Environment Built on Trust and Accountability

The company strengthens this philosophy through the Organizational Transformation Framework, which integrates its purpose, values, long-term strategy, cultural development, and execution.

Our vision blends innovation with inclusivity, creating a foundation for more equitable and efficient healthcare access across the region

Grupo Dökka creates an environment built on trust and accountability. Within this structure, individuals reach their Single Point of Accountability, or SPA, when they fully own their role.

Technology plays a crucial role in this transformation. Grupo Dökka embraces Hybrid Intelligence, a blend of artificial intelligence and human expertise. The company uses predictive analytics to strengthen supply chains and relies on a robust customer relationship management system to personalize care. These tools enhance rather than replace human capability, ensuring that patients and clients always remain at the center.
Lives Changed Matters

Sustainability is also defined in human terms. Rather than focusing solely on environmental metrics, Grupo Dökka measures success through a single KPI: lives changed. This philosophy drives both internal and external initiatives. Employees benefit from funds for catastrophic diseases, social aid, and scholarships.

Communities benefit from wellness campaigns such as the Fischel 8k Race, sponsoring mobile mammograms under the “Ya es Hora” alliance, and awareness efforts during Pink Month and Movember. Customers, tiny pharmacies in Costa Rica, benefit from the Cefa Plus program, which provides financing, technology, and knowledge to ensure their survival in a market dominated by larger players.

Further, the company has developed comprehensive disaster recovery and business continuity plans to mitigate global disruptions such as pandemics. At the same time, close collaboration with suppliers ensures that potential challenges are anticipated and addressed in advance.

One recent success illustrates Grupo Dökka’s impact. In Costa Rica, small independent pharmacies represent nearly 35 percent of the market. These businesses are vital for rural healthcare access, yet they face pressure from larger competitors. Through the Cefa Plus program, Grupo Dökka has supported its sustainability, offering competitive prices, financial options, and technical support. As a result, these pharmacies have maintained market share and continued serving their communities, demonstrating the company’s commitment to inclusivity and access.

Catalyst for Healthier, Stronger Communities

Looking forward, Grupo Dökka will continue building on its distribution, retail, biomedical equipment, and digital ecosystems pillars.

By combining leadership rooted in trust, technology guided by human values, and a sustainability strategy measured by lives changed, the company is reshaping healthcare distribution in Latin America.

In every aspect of its work, Grupo Dökka is more than a distributor. It is a catalyst for healthier, stronger communities across Latin America.

Top Pharmaceutical Medicines Distribution Company in Latin America - 2025
Current Issue

Company : Grupo Dökka

Management
Eduardo Jiliberto, CEO

Thank you for Subscribing to Life Science Review Weekly Brief

Life Sciences Review
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/grupo-dokka